Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 11, 2025 03:48 ET | Source: Transparency Market Research

Neuroregeneration Therapy Market to Surpass USD 64.8 Billion by 2034, Driven by Advancements in Regenerative Medicine and Rising Neurological Disorders | Transparency Market Research

Wilmington, Delaware, Transparency Market Research Inc. – , Feb. 11, 2025 (GLOBE NEWSWIRE) -- The global neuroregeneration therapy market (Markt für Neuroregenerationstherapie )was valued at...
August 19, 2024 08:25 ET | Source: Polaris Market Research & Consulting LLP

Multiple Sclerosis Market Set to Reach USD 33.57 Billion by 2032, Growing at a CAGR of 5.4% | Polaris Market Research (PMR)

New York, USA, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Market Overview: The multiple sclerosis market was estimated at USD 21.04 billion in 2023. The market valuation is expected to be USD 33.57 billion...
December 04, 2023 07:09 ET | Source: Tiziana Life Sciences Ltd.

Tiziana Life Sciences to Present at the Webull LIVE! with Corporate Connect: Biotech Investment Webinar

NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
January 11, 2023 07:00 ET | Source: Emerald Health Pharmaceuticals

Emerald Health Pharmaceuticals Receives Safety Review Committee Approval to Proceed to Final Cohorts of EHP-101 Phase 2a Systemic Sclerosis Trial

SAN DIEGO, CA, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (“EHP” or the “Company”), a clinical-stage biopharmaceutical company developing a new class of medicines to treat...
April 13, 2022 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces FDA Orphan Drug Designation for Efzofitimod (ATYR1923) for Treatment of Systemic Sclerosis

SAN DIEGO, April 13, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotherapeutics company engaged in the discovery and development of innovative medicines based on...
March 02, 2020 02:32 ET | Source: AB Science

AB Science réalise une levée de fonds de 12,3 millions d'euros

NE DOIT PAS ETRE DISTRIBUE OU PUBLIE, DIRECTEMENT OU INDIRECTEMENT, AUX ETATS-UNIS D’AMERIQUE, AU CANADA, EN AUSTRALIE OU AU JAPON COMMUNIQUE DE PRESSE AB SCIENCE REALISE UNE LEVEE DE FONDS DE 12,3...
March 02, 2020 02:32 ET | Source: AB Science

AB Science announces a new fundraising of EUR 12.3 million

NOT FOR DISTRIBUTION, PUBLICATION, RELEASE, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN REGULATED INFORMATION FOR IMMEDIATE RELEASE AB SCIENCE ANNOUNCES A NEW...
December 23, 2019 08:30 ET | Source: Endonovo Therapeutics, Inc.

Endonovo Therapeutics Provides SofPulse® To All NFL Teams

Los Angeles, CA, Dec. 23, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today the delivery of SofPulse® evaluation units to all...